Clinical Trials Sponsored by ChemRar Research and Development Institute, LLC

Total 807 results

ChemRar Research and Development Institute, LLC

Completed

А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Anxiety Disorder Generalized

Russian Federation
ChemRar Research and Development Institute, LLC

Not yet recruiting

A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Anxiety Disorder Generalized
Finch Research and Development LLC.

Terminated

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) (PRISM4)

Recurrent C. Difficile Infection

United States, Canada
Finch Research and Development LLC.

Completed

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff (PRISM3)

Clostridium Difficile Infection Recurrence

Canada, United States
Finch Research and Development LLC.

Withdrawn

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT) (SPROUT)

Autism Spectrum Disorder | Autism | ASD | FMT | Fecal Transplant | Autistic Thinking | Autistic Behavior | Fecal Microbiota Transplant | Finch | CP101 | SPROUT
IRIS Research and Development, LLC
Mallinckrodt

Completed

Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS) (CLIPS)

Psoriatic Arthritis

United States
Janssen Research & Development, LLC
The Scripps Research Institute

Withdrawn

Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults

Alcoholism

United States
Aptevo Research and Development LLC

Recruiting

Study of APVO436 in Patients With AML or MDS

AML | MDS

United States
Finch Research and Development LLC.
Medpace, Inc.

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT)

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal Transplant

United States, Canada
The Rogosin Institute
Janssen Research & Development, LLC

Completed

Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease

Proteinuria | Chronic Kidney Disease | Kidney Injury

United States
Bayer
Janssen Research & Development, LLC; Population Health Research Institute

Terminated

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS) (NAVIGATE ESUS)

Stroke

Denmark, France, Spain, China, United States, Switzerland, Germany, Greece, Korea, Republic of, Portugal, Japan, Israel, Canada, Australia, Turkey, Russian Federation, Sweden, Austria, Czechia, Poland, United Kingdom, Belgium, Brazil, Hungar... and more
Bayer
Janssen Research & Development, LLC; Population Health Research Institute

Completed

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

Prevention & Control

Belgium, Finland, France, China, United States, Colombia, Ireland, Philippines, Japan, Hungary, Canada, Germany, Australia, Chile, Czechia, Korea, Republic of, Malaysia, Brazil, Denmark, Israel, Russian Federation, South Africa, Ecu... and more
VA Office of Research and Development
Stumpworx LLC

Not yet recruiting

Improving Prosthetic Arms for Amputee: A Better Fit and More Functionality (KSH)

Amputation, Surgical

United States
Deka Research and Development
CVS Kidney Care LLC.

Completed

An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System

End Stage Renal Disease

United States
Deka Research and Development
CVS Kidney Care LLC.

Completed

Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD

End-Stage Renal Disease

United States
Dana-Farber Cancer Institute
Janssen Research & Development, LLC

Active, not recruiting

Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer

Castration-resistant Prostate Cancer

United States
Dana-Farber Cancer Institute
Janssen Research & Development, LLC

Recruiting

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

Multiple Myeloma | Smoldering Multiple Myeloma

United States
Carla Greenbaum, MD
Janssen Research & Development, LLC

Completed

Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes

Type 1 Diabetes

United States
National Development and Research Institutes, Inc.

Unknown

The Staying Safe Intervention (Ssafe)

Hepatitis C | Opioid Use

United States
National Development and Research Institutes, Inc.

Unknown

Increasing HIV Testing in Urban Emergency Departments Via Mobile Technology

HIV Testing

United States
Pharm-Olam, LLC
Biomedical Advanced Research and Development Authority

Terminated

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents (CoVacSpec)

COVID-19

United States, South Africa, Colombia, Guadeloupe, India, Mexico, Puerto Rico
Pfizer
Janssen Alzheimer Immunotherapy (JAI) Research and Development, LLC

Completed

Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

Spain, France, Germany
National Development and Research Institutes, Inc.

Unknown

Applying Web Technology to Buprenorphine Treatment

Adult Opioid-Dependence

United States
National Development and Research Institutes, Inc.

Unknown

Mobile Intervention for Young Opioid Users

Opioid-Related Disorders

United States
AbbVie
Janssen Research & Development LLC; Pharmacyclics LLC (An AbbVie Company)

Completed

Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury (iNSPIRE)

CoronaVirus Induced Disease-2019 (COVID-19)

United States
DHR Health Institute for Research and Development

Recruiting

PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

COVID-19 | SARS CoV 2 Infection

United States
DHR Health Institute for Research and Development

Withdrawn

Online Spanish Cognitive Intervention Program for Spanish-Speaking Latino/Hispanic Subarachnoid Hemorrhage Patients

Quality of Life | Cognitive Impairment | Subarachnoid Hemorrhage | Depression, Anxiety

United States
DHR Health Institute for Research and Development

Approved for marketing

Omegaven Protocol:Intermediate Size Patient Population

Parenteral Nutrition Associated Liver Disease
DBL -Institute for Health Research and Development

Completed

Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of Treatment

Malaria | Iron Deficiency | Anaemia | Schistosomiasis Infection

Kenya
DBL -Institute for Health Research and Development

Completed

Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia

Anaemia | Schistosomiasis | Helminthiases

Zambia
DBL -Institute for Health Research and Development

Completed

Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina Faso

Schistosomiasis
Janssen Research & Development, LLC
Harvard Medical School (HMS and HSDM); Bayer; Duke Clinical Research Institute

Completed

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome (GEMINI ACS 1)

Acute Coronary Syndrome

United States, France, Poland, Ukraine, Belgium, Spain, Argentina, Bulgaria, Russian Federation, Turkey, Japan, Canada, Netherlands, Korea, Republic of, Brazil, Australia, Hungary, Sweden, Czechia, Denmark
DBL -Institute for Health Research and Development

Completed

Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania

Malaria | Anaemia | Hepatosplenomegaly

Tanzania
DBL -Institute for Health Research and Development

Completed

Safety and Efficacy of Drug Combinations Against Schistosomiasis

Parasitic Diseases

Uganda
DBL -Institute for Health Research and Development

Completed

Safety and Efficacy of Drug Combinations Against Trichuris Trichiura

Parasitic Diseases

Uganda
DBL -Institute for Health Research and Development

Completed

Safety and Efficacy of Drug Combinations Against Triple Infections

Parasitic Diseases

Uganda
IKFE Institute for Clinical Research and Development

Completed

Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes

Diabetes Mellitus

Germany
DBL -Institute for Health Research and Development

Completed

Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya

Schistosomiasis Mansoni | Circulating Cathodic Antigen Urine Based Dipstick

Kenya
Medaxis, LLC
Professional Education and Research Institute

Recruiting

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

Diabetic Foot | Diabetic Foot Ulcer

United States
VA Office of Research and Development
Merck Sharp & Dohme LLC

Recruiting

A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation (CHOMP)

Metastatic Castration Resistant Prostate Cancer

United States
DHR Health Institute for Research and Development

Terminated

"Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance

Barrett's Esophagus

United States
DHR Health Institute for Research and Development

Completed

Exoskeleton Rehabilitation on TBI (Ekso-TBI)

Traumatic Brain Injury | Cerebral Stroke

United States
DBL -Institute for Health Research and Development

Completed

Schistosoma Mansoni in Mwanza Region, Tanzania (SCORE_PAR)

Schistosoma Mansoni

Tanzania
DBL -Institute for Health Research and Development

Completed

Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment

Malaria | Anaemia

Ghana
DBL -Institute for Health Research and Development

Completed

Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes

Helminthiasis | Anaemia | Schistosomiasis

Uganda
IKFE Institute for Clinical Research and Development

Completed

Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin (PIOswitch)

Type 2 Diabetes Mellitus | Insulin Resistance

Germany
DBL -Institute for Health Research and Development

Completed

Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana

Schistosomiasis | Soil-Transmitted Helminthiasis

Ghana
Public Health Vaccines LLC
Biomedical Advanced Research and Development Authority

Recruiting

Study to Evaluate the Recombinant Vesicular Stomatitis Virus (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects (PHV01)

Marburg Virus Disease

United States
MENA Center for Research & Development and Internship
Merck Sharp & Dohme LLC

Recruiting

The Epidemiology , Health and Economic Burden of RSV Amongst Hospitalized Children Under 5 Years of Age in Jordan (RSV-JO)

Respiratory Syncytial Virus Infections

Jordan
University of California, Los Angeles
OpenBiome; Finch Research and Development LLC.

Withdrawn

Pilot Study Using Oral Capsule FMT to Decolonize GI CRE

Enterobacteriaceae Infections | Fecal Microbiota Transplantation

Clinical Trials Sponsored by ChemRar Research and Development Institute, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations